Home/Pipeline/RASTRUM™ 3D Alzheimer’s Disease Model

RASTRUM™ 3D Alzheimer’s Disease Model

Alzheimer’s disease

Pre‑clinicalActive

Key Facts

Indication

Alzheimer’s disease

Phase

Pre‑clinical

Status

Active

Company

Inventia delivers high‑throughput 3D bioprinting platforms that generate assay‑ready disease models for faster, more predictive drug discovery.

Drug	Company	Phase	Status
SPC-14	Silo Pharma	Preclinical	Research
Masitinib	AB Science	Phase 3	Active
Vaxine Alzheimer’s Disease Vaccine	Vaxine	Preclinical	Active
Leronlimab	CytoDyn	Phase 1	Phase in progress
Sovateltide	Pharmazz	Preclinical	Active
Alzheimer's Drug	Dawah Pharmaceuticals	Development	Active
Alzheimer’s Clinical Trials	Boston Clinical Trials	Not Specified (Typically Phase 2-3)	Active
ONO-2020	Deciphera Pharmaceuticals	Phase 2	Active
Blarcamesine (ANAVEX®2-73)	Anavex Life Sciences	Phase 2b/3	Ongoing